**Strong IPO momentum in late 2026, anchored by Anthropic’s planned $61 billion Nasdaq offering priced around November 19, has driven elevated trader expectations for activity before year-end.** Multiple deals have already priced in mid-November, including Windward Bio Group (WWB) and vVARDIS Holding (VVVV) at $175 million each, alongside smaller U.S. and international listings such as Bluerock Acquisition Corp. II. Recent data show 83 traditional IPOs raising over $120 billion through September, with the fourth-quarter pipeline—including AI and biotech issuers—supported by robust order books and a rebound in the IPOX index. Key catalysts ahead include additional November pricings and potential December filings, though execution remains sensitive to equity volatility, Treasury yields, and AI valuation scrutiny. This activity reflects skin-in-the-game consensus that the window stays open through December.
基于Polymarket数据的AI实验性摘要。这不是交易建议,也不影响该市场的结算方式。 · 更新于1H6H1D7D30DALL
View resolved





























警惕外部链接哦。
警惕外部链接哦。
常见问题